Andrew Crumpton

Articles by Andrew Crumpton

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

ByAndrew Crumpton,Adrian Parkinson,Holger Memmesheimer,Svetlana Lyapustina,Kevin Hawkins,David Christopher,Sebastian Kaerger,Bruce Wyka,Andy Rignall,Mary Ann Smith

October 1st 2008

The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.

Latest Updated Articles

Quality by Design for analytical methods for use with orally inhaled and nasal drug products
Published: October 1st 2008 | Updated:

Andrew Crumpton

Articles by Andrew Crumpton

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

Latest Updated Articles

Trending on Pharmaceutical Technology

Kimberly-Clark to Buy Tylenol Maker Kenvue: Analyzing Risks and Rewards

How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience